Hydroa vacciniforme-like lymphoproliferative disorder in Korea
Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein–Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. We investigated the characteristics of HVLPD in Korean patients....
Gespeichert in:
| Veröffentlicht in: | Scientific reports 2020-11, Vol.10 (1), p.19294-19294, Article 19294 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 19294 |
|---|---|
| container_issue | 1 |
| container_start_page | 19294 |
| container_title | Scientific reports |
| container_volume | 10 |
| creator | Han, Byeol Hur, Keunyoung Ohn, Jungyoon Kim, Tae Min Jeon, Yoon Kyung Kim, You Chan Mun, Je-Ho |
| description | Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein–Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. We investigated the characteristics of HVLPD in Korean patients. HVLPD patients at Seoul National University Hospital between 1988 and 2019 were retrospectively analyzed. This study included 26 HVLPD patients who all presented with recurrent papulovesicular and necrotic eruption on the face, neck, and extremities. EBV was detected from the skin tissues of all patients. HVLPD was diagnosed during childhood (age |
| doi_str_mv | 10.1038/s41598-020-76345-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7652856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2459352849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c522t-879d21ce9e9832008f420a9f3deebb073b5373c7a8b3faac328637cad1087b9f3</originalsourceid><addsrcrecordid>eNp9kctKxDAUhoMoOqgv4EIKbtxUc2maZDMggzcccKPrkKanM9G2GZOZgXl7o_W-MJscON_5k8OH0BHBZwQzeR4LwpXMMcW5KFnBc7qFRhS_FYzS7R_1HjqM8Qmnw6kqiNpFe4yRUsqyGKHxzaYO3mRrY63rXeNDB3nrniFrN91i7hfBt66BYJZuDVntog81hMz12Z0PYA7QTmPaCIcf9z56vLp8mNzk0_vr28nFNLec0mUuhaopsaBASUYxlk1BsVENqwGqCgtWcSaYFUZWrDHGMipLJqypCZaiStw-Gg-5i1XVQW2hXwbT6kVwnQkb7Y3Tvzu9m-uZX2tRcip5mQJOPwKCf1lBXOrORQtta3rwq6hpwRVLaKESevIHffKr0Kf1EiUI5xwTnig6UDb4GAM0X58hWL8Z0oMhnQzpd0OapqHjn2t8jXz6SAAbgJha_QzC99v_xL4C6NyccQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471555015</pqid></control><display><type>article</type><title>Hydroa vacciniforme-like lymphoproliferative disorder in Korea</title><source>MEDLINE</source><source>PubMed Central(OpenAccess)</source><source>SpringerOpen website</source><source>DOAJ Directory of Open Access Journals</source><source>Free Full-Text Journals in Chemistry</source><source>EZB Electronic Journals Library</source><source>Nature出版集团开放获取期刊</source><creator>Han, Byeol ; Hur, Keunyoung ; Ohn, Jungyoon ; Kim, Tae Min ; Jeon, Yoon Kyung ; Kim, You Chan ; Mun, Je-Ho</creator><creatorcontrib>Han, Byeol ; Hur, Keunyoung ; Ohn, Jungyoon ; Kim, Tae Min ; Jeon, Yoon Kyung ; Kim, You Chan ; Mun, Je-Ho</creatorcontrib><description>Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein–Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. We investigated the characteristics of HVLPD in Korean patients. HVLPD patients at Seoul National University Hospital between 1988 and 2019 were retrospectively analyzed. This study included 26 HVLPD patients who all presented with recurrent papulovesicular and necrotic eruption on the face, neck, and extremities. EBV was detected from the skin tissues of all patients. HVLPD was diagnosed during childhood (age < 18 years) in seven patients (26.9%) and in adulthood (age ≥ 18 years) in 19 cases (73.1%). The median age at diagnosis was 24.0 years (range 7–70 years). HVLPD has various clinical courses, from an indolent course to progression to systemic lymphoma. Fourteen patients (53.8%) developed lymphoma: systemic EBV-positive T-cell lymphoma (n = 9, 34.6%); extranodal natural killer/T-cell lymphoma, nasal type (n = 3, 11.5%); aggressive natural killer/T-cell leukemia (n = 1, 3.8%); and EBV-positive Hodgkin lymphoma (n = 1, 3.8%). Mortality due to HVLPD occurred in five patients (26.3%) in the adult group, while it was one patient (14.3%) in the child group. As lymphoma progression and mortality occur not only in childhood but also in adulthood, adult-onset cases may need more careful monitoring.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-020-76345-2</identifier><identifier>PMID: 33168864</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/1990 ; 692/4028 ; 692/699/1541 ; 692/699/4033 ; 692/699/67 ; Adolescent ; Adult ; Adults ; Age ; Aged ; Child ; Children ; Disease Progression ; Epstein-Barr virus ; Epstein-Barr Virus Infections - epidemiology ; Epstein-Barr Virus Infections - virology ; Extremities ; Female ; Herpesvirus 4, Human ; Hodgkin's lymphoma ; Humanities and Social Sciences ; Humans ; Hydroa Vacciniforme - diagnosis ; Hydroa Vacciniforme - epidemiology ; Hydroa Vacciniforme - pathology ; Hydroa Vacciniforme - virology ; Immunoproliferative diseases ; Leukemia ; Lymphatic diseases ; Lymphocytes ; Lymphocytes T ; Lymphoma ; Lymphoma, T-Cell - epidemiology ; Lymphoma, T-Cell - virology ; Lymphoproliferative Disorders - epidemiology ; Lymphoproliferative Disorders - virology ; Male ; Middle Aged ; Mortality ; multidisciplinary ; Natural killer cells ; Necrosis ; Patients ; Republic of Korea - epidemiology ; Retrospective Studies ; Science ; Science (multidisciplinary) ; Skin - metabolism ; Skin - pathology ; Skin Neoplasms - epidemiology ; Skin Neoplasms - virology ; T-cell lymphoma ; Young Adult</subject><ispartof>Scientific reports, 2020-11, Vol.10 (1), p.19294-19294, Article 19294</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c522t-879d21ce9e9832008f420a9f3deebb073b5373c7a8b3faac328637cad1087b9f3</citedby><cites>FETCH-LOGICAL-c522t-879d21ce9e9832008f420a9f3deebb073b5373c7a8b3faac328637cad1087b9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652856/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652856/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33168864$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Byeol</creatorcontrib><creatorcontrib>Hur, Keunyoung</creatorcontrib><creatorcontrib>Ohn, Jungyoon</creatorcontrib><creatorcontrib>Kim, Tae Min</creatorcontrib><creatorcontrib>Jeon, Yoon Kyung</creatorcontrib><creatorcontrib>Kim, You Chan</creatorcontrib><creatorcontrib>Mun, Je-Ho</creatorcontrib><title>Hydroa vacciniforme-like lymphoproliferative disorder in Korea</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein–Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. We investigated the characteristics of HVLPD in Korean patients. HVLPD patients at Seoul National University Hospital between 1988 and 2019 were retrospectively analyzed. This study included 26 HVLPD patients who all presented with recurrent papulovesicular and necrotic eruption on the face, neck, and extremities. EBV was detected from the skin tissues of all patients. HVLPD was diagnosed during childhood (age < 18 years) in seven patients (26.9%) and in adulthood (age ≥ 18 years) in 19 cases (73.1%). The median age at diagnosis was 24.0 years (range 7–70 years). HVLPD has various clinical courses, from an indolent course to progression to systemic lymphoma. Fourteen patients (53.8%) developed lymphoma: systemic EBV-positive T-cell lymphoma (n = 9, 34.6%); extranodal natural killer/T-cell lymphoma, nasal type (n = 3, 11.5%); aggressive natural killer/T-cell leukemia (n = 1, 3.8%); and EBV-positive Hodgkin lymphoma (n = 1, 3.8%). Mortality due to HVLPD occurred in five patients (26.3%) in the adult group, while it was one patient (14.3%) in the child group. As lymphoma progression and mortality occur not only in childhood but also in adulthood, adult-onset cases may need more careful monitoring.</description><subject>631/67/1990</subject><subject>692/4028</subject><subject>692/699/1541</subject><subject>692/699/4033</subject><subject>692/699/67</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Adults</subject><subject>Age</subject><subject>Aged</subject><subject>Child</subject><subject>Children</subject><subject>Disease Progression</subject><subject>Epstein-Barr virus</subject><subject>Epstein-Barr Virus Infections - epidemiology</subject><subject>Epstein-Barr Virus Infections - virology</subject><subject>Extremities</subject><subject>Female</subject><subject>Herpesvirus 4, Human</subject><subject>Hodgkin's lymphoma</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hydroa Vacciniforme - diagnosis</subject><subject>Hydroa Vacciniforme - epidemiology</subject><subject>Hydroa Vacciniforme - pathology</subject><subject>Hydroa Vacciniforme - virology</subject><subject>Immunoproliferative diseases</subject><subject>Leukemia</subject><subject>Lymphatic diseases</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Lymphoma</subject><subject>Lymphoma, T-Cell - epidemiology</subject><subject>Lymphoma, T-Cell - virology</subject><subject>Lymphoproliferative Disorders - epidemiology</subject><subject>Lymphoproliferative Disorders - virology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>multidisciplinary</subject><subject>Natural killer cells</subject><subject>Necrosis</subject><subject>Patients</subject><subject>Republic of Korea - epidemiology</subject><subject>Retrospective Studies</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Skin - metabolism</subject><subject>Skin - pathology</subject><subject>Skin Neoplasms - epidemiology</subject><subject>Skin Neoplasms - virology</subject><subject>T-cell lymphoma</subject><subject>Young Adult</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kctKxDAUhoMoOqgv4EIKbtxUc2maZDMggzcccKPrkKanM9G2GZOZgXl7o_W-MJscON_5k8OH0BHBZwQzeR4LwpXMMcW5KFnBc7qFRhS_FYzS7R_1HjqM8Qmnw6kqiNpFe4yRUsqyGKHxzaYO3mRrY63rXeNDB3nrniFrN91i7hfBt66BYJZuDVntog81hMz12Z0PYA7QTmPaCIcf9z56vLp8mNzk0_vr28nFNLec0mUuhaopsaBASUYxlk1BsVENqwGqCgtWcSaYFUZWrDHGMipLJqypCZaiStw-Gg-5i1XVQW2hXwbT6kVwnQkb7Y3Tvzu9m-uZX2tRcip5mQJOPwKCf1lBXOrORQtta3rwq6hpwRVLaKESevIHffKr0Kf1EiUI5xwTnig6UDb4GAM0X58hWL8Z0oMhnQzpd0OapqHjn2t8jXz6SAAbgJha_QzC99v_xL4C6NyccQ</recordid><startdate>20201109</startdate><enddate>20201109</enddate><creator>Han, Byeol</creator><creator>Hur, Keunyoung</creator><creator>Ohn, Jungyoon</creator><creator>Kim, Tae Min</creator><creator>Jeon, Yoon Kyung</creator><creator>Kim, You Chan</creator><creator>Mun, Je-Ho</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201109</creationdate><title>Hydroa vacciniforme-like lymphoproliferative disorder in Korea</title><author>Han, Byeol ; Hur, Keunyoung ; Ohn, Jungyoon ; Kim, Tae Min ; Jeon, Yoon Kyung ; Kim, You Chan ; Mun, Je-Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c522t-879d21ce9e9832008f420a9f3deebb073b5373c7a8b3faac328637cad1087b9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/67/1990</topic><topic>692/4028</topic><topic>692/699/1541</topic><topic>692/699/4033</topic><topic>692/699/67</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Adults</topic><topic>Age</topic><topic>Aged</topic><topic>Child</topic><topic>Children</topic><topic>Disease Progression</topic><topic>Epstein-Barr virus</topic><topic>Epstein-Barr Virus Infections - epidemiology</topic><topic>Epstein-Barr Virus Infections - virology</topic><topic>Extremities</topic><topic>Female</topic><topic>Herpesvirus 4, Human</topic><topic>Hodgkin's lymphoma</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hydroa Vacciniforme - diagnosis</topic><topic>Hydroa Vacciniforme - epidemiology</topic><topic>Hydroa Vacciniforme - pathology</topic><topic>Hydroa Vacciniforme - virology</topic><topic>Immunoproliferative diseases</topic><topic>Leukemia</topic><topic>Lymphatic diseases</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Lymphoma</topic><topic>Lymphoma, T-Cell - epidemiology</topic><topic>Lymphoma, T-Cell - virology</topic><topic>Lymphoproliferative Disorders - epidemiology</topic><topic>Lymphoproliferative Disorders - virology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>multidisciplinary</topic><topic>Natural killer cells</topic><topic>Necrosis</topic><topic>Patients</topic><topic>Republic of Korea - epidemiology</topic><topic>Retrospective Studies</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Skin - metabolism</topic><topic>Skin - pathology</topic><topic>Skin Neoplasms - epidemiology</topic><topic>Skin Neoplasms - virology</topic><topic>T-cell lymphoma</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Byeol</creatorcontrib><creatorcontrib>Hur, Keunyoung</creatorcontrib><creatorcontrib>Ohn, Jungyoon</creatorcontrib><creatorcontrib>Kim, Tae Min</creatorcontrib><creatorcontrib>Jeon, Yoon Kyung</creatorcontrib><creatorcontrib>Kim, You Chan</creatorcontrib><creatorcontrib>Mun, Je-Ho</creatorcontrib><collection>SpringerOpen website</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Byeol</au><au>Hur, Keunyoung</au><au>Ohn, Jungyoon</au><au>Kim, Tae Min</au><au>Jeon, Yoon Kyung</au><au>Kim, You Chan</au><au>Mun, Je-Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hydroa vacciniforme-like lymphoproliferative disorder in Korea</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2020-11-09</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>19294</spage><epage>19294</epage><pages>19294-19294</pages><artnum>19294</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein–Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. We investigated the characteristics of HVLPD in Korean patients. HVLPD patients at Seoul National University Hospital between 1988 and 2019 were retrospectively analyzed. This study included 26 HVLPD patients who all presented with recurrent papulovesicular and necrotic eruption on the face, neck, and extremities. EBV was detected from the skin tissues of all patients. HVLPD was diagnosed during childhood (age < 18 years) in seven patients (26.9%) and in adulthood (age ≥ 18 years) in 19 cases (73.1%). The median age at diagnosis was 24.0 years (range 7–70 years). HVLPD has various clinical courses, from an indolent course to progression to systemic lymphoma. Fourteen patients (53.8%) developed lymphoma: systemic EBV-positive T-cell lymphoma (n = 9, 34.6%); extranodal natural killer/T-cell lymphoma, nasal type (n = 3, 11.5%); aggressive natural killer/T-cell leukemia (n = 1, 3.8%); and EBV-positive Hodgkin lymphoma (n = 1, 3.8%). Mortality due to HVLPD occurred in five patients (26.3%) in the adult group, while it was one patient (14.3%) in the child group. As lymphoma progression and mortality occur not only in childhood but also in adulthood, adult-onset cases may need more careful monitoring.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33168864</pmid><doi>10.1038/s41598-020-76345-2</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2045-2322 |
| ispartof | Scientific reports, 2020-11, Vol.10 (1), p.19294-19294, Article 19294 |
| issn | 2045-2322 2045-2322 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7652856 |
| source | MEDLINE; PubMed Central(OpenAccess); SpringerOpen website; DOAJ Directory of Open Access Journals; Free Full-Text Journals in Chemistry; EZB Electronic Journals Library; Nature出版集团开放获取期刊 |
| subjects | 631/67/1990 692/4028 692/699/1541 692/699/4033 692/699/67 Adolescent Adult Adults Age Aged Child Children Disease Progression Epstein-Barr virus Epstein-Barr Virus Infections - epidemiology Epstein-Barr Virus Infections - virology Extremities Female Herpesvirus 4, Human Hodgkin's lymphoma Humanities and Social Sciences Humans Hydroa Vacciniforme - diagnosis Hydroa Vacciniforme - epidemiology Hydroa Vacciniforme - pathology Hydroa Vacciniforme - virology Immunoproliferative diseases Leukemia Lymphatic diseases Lymphocytes Lymphocytes T Lymphoma Lymphoma, T-Cell - epidemiology Lymphoma, T-Cell - virology Lymphoproliferative Disorders - epidemiology Lymphoproliferative Disorders - virology Male Middle Aged Mortality multidisciplinary Natural killer cells Necrosis Patients Republic of Korea - epidemiology Retrospective Studies Science Science (multidisciplinary) Skin - metabolism Skin - pathology Skin Neoplasms - epidemiology Skin Neoplasms - virology T-cell lymphoma Young Adult |
| title | Hydroa vacciniforme-like lymphoproliferative disorder in Korea |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A44%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hydroa%20vacciniforme-like%20lymphoproliferative%20disorder%20in%20Korea&rft.jtitle=Scientific%20reports&rft.au=Han,%20Byeol&rft.date=2020-11-09&rft.volume=10&rft.issue=1&rft.spage=19294&rft.epage=19294&rft.pages=19294-19294&rft.artnum=19294&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-020-76345-2&rft_dat=%3Cproquest_pubme%3E2459352849%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2471555015&rft_id=info:pmid/33168864&rfr_iscdi=true |